4Tiseo M,Ardizzoni A,Cafferata M A,et al.Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.Anticancer Res,2008,28:507-513.
5Mizuguchi S,Nishiyama N,Iwata T,et al.Clinical value of serum cytokeratin 19 fragment and sialyl-lewis X in non-small cell lung cancer.Ann Thorac Surg,2007,83:216-221.
5Nonaka M, Kataoka D, Yamamoto S, et al. Pre-and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Ann Thorac Cardiovase Surg, 2004,10:281.
6Giovanella L, Ceriani L, Bandera M, et al. Evaluation of the serum markers CEA, NSE, TIcS and CYFRA 21. 1 in lung cancer. Int J Biol Markers, 1995,10:156-160.
7Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem, 2004,37 : 529-540.
8Buccheri G, Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer, 2001,34 Suppl 2:S65-69.
9Lamy P, Grenier J, Kramer A, et al. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer, 2000,29: 197- 203.
10Ebert W, Dienemann H, Fateh-Moghadam A, et al. Cytokeratin fragment CYFRA 21.1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer: results of an international muhicentre study. Eur J Clin Chem Clin Biochem, 1994,32:189-199.
4Xue A,Scarlett CJ,Chung L,et al.Discovery of serum biomarkers for pancreatic adenocarcinoma using pruteomic analysis.Br J Cancer,2010,103:391-400.
5Kawai S,Suzuki K,Nishio K,et al.Smoking and serum CA199 levels according to Lewis and secretor genotypes.Int J Cancer,2008,123..2880-2884.
6Radaideh SM,Kesler KA,Einhorn LH.Outcome following resection for patients with primary mediastinal nonseminomatous germ cell tumors and rising serum tumor markers post chemotherapy.Ann Oncol,2010,21:804-807.
7Hatate K,Yamashita HK,Kumamoto H.Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A,3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.Oncol Reports,2008,20:737-743.
8Nohamna L,Hanrik B.Serum HCG-β and CA72-4 are stronger prognostic factors than CA50,CA199 and CA242 in pancreatic cancer.Oncology,2010,82:134-139.
